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Abstract 
A cDNA clone coding for human protein kinase CKI (casein kinase 1) has been isolated and sequenced emonstrating that it corresponds to a 
homolog of the CKla form found in bovine brain. The derived amino acid sequence of the human CKlcl is identical to the bovine counterpart except 
that it contains I2 extra amino acids at the carboxyl end. Using this cDNA sequence and PCR amplification, YAC genomic clones that contain this 
human CKla sequence have been isolated. These YACs have been used for fluorescent in situ hybridization in order to localize the human CKla 
gene to chromosome 13q13. 
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I. Introduction 
Protein kinase CKl (previously known as casein ki- 
nase 1) is a ubiquitous ser/thr protein kinase that has 
been found in the nucleus, cytoplasm and membrane 
fractions of eukaryotic cells (see reviews [l-2]). This 
abundant enzyme is a monomeric (34-55 kDa) protein 
that does not seem to be regulated by the well-known 
second messengers involved in signal transduction. 
Several findings contribute to the interest in studying 
this enzyme. It has been observed, for instance, that CKl 
phosphorylates a number of important proteins such as 
RNA polymerases I and II, the SV-40 large T antigen, 
the p53 tumor suppressor protein and the mRNA cap- 
binding protein [2]. CKl has also been reported to par- 
ticipate in the hierarchal phosphorylation of glycogen 
synthase with the CAMP-dependent protein kinase [3]. 
Immunofluorescent studies using mouse fibroblasts 
and CHO cells localized CKl in vesicular structures dur- 
ing interphase. During mitosis, however, this enzyme is 
concentrated in the mitotic spindle, in the centrosome as 
well as in the kinetochore microtubules [4]. Also relevant 
to a possible involvement of CKl in cell division is the 
finding that a yeast mutant (HRR25) which was found 
to cause defects in DNA strand-break repair has turned 
out to be highly homologous to CKl [5]. HRR25 mu- 
tants are also defective in meiosis and show delays in 
G1-M phase transition in the cell cycle. 
Several genes coding for CKl have been described 
*Corresponding author. Fax: (56) (2) 737 6320. 
[C&8]. In yeast the genes YCKl and YCK2 were isolated 
independently. YCKl was isolated as a suppressor of the 
requirement of SNF4 function, while increased dosage 
of YCK2 allows cells to survive extreme salinity. These 
two genes were found to be very similar to each other and 
64% identical to a fraction of rabbit CKl . Loss of func- 
tion of either of these genes shows no detectable pheno- 
type but when both genes are lost the cells are not viable 
[6]. The deduced proteins from these genes have esti- 
mated M, of 61,000-62,000, which is significantly larger 
than the enzyme found in animal cells. 
In bovine brain, cDNAs coding for 4 different but 
homologous subspecies of CKl have been reported [7]. 
The a and j? subspecies were 37 and 38 kDa proteins, 
respectively. In rat testis, a cDNA clone was isolated 
which coded for a 49 kDa casein kinase subspecies called 
6, which is 76% identical to bovine 01 and 75% identical 
to HRR25 [8]. 
Recently, our laboratory has cloned cDNA encoding 
a Xenopus Zaevis casein kinase 1 which is very similar to 
the bovine 01 subspecies (Tapia, C. et al., manuscript in 
preparation). Partial amino acid sequences obtained 
from purified peptides of human CKl were reported [4]. 
These X. laevis and human amino acid sequences are 
identical to the bovine CKla subspecies. 
This report presents the cloning and sequence of a 
cDNA containing the complete coding region of the 
human CKl gene which was found to be highly homolo- 
gous to the bovine CKla amino acid sequence. Also 
yeast artificial chromosomes (YACs) containing human 
inserts, that include the same or homologous CKla se- 
quence have been identified and used to localize the gene 
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through fluorescent in situ hybridization to chromosome 
region 13q13. 
2. Materials and methods 
2.1. Cloning of the human CKla cDNA 
Primers were synthesized on the basis of the published bovine se- 
quences that are common to all CKl species [7]. These primers had the 
sequences 5’-CCC AGA TAA CTT CCT AAG GGG-3’ and S-AGC 
CTT TAG TCC TTC CAT GGA-3’ and were used for PCR amplifica- 
tion of human fetal brain 1ZAP (Stratagene) cDNA library. A fragment 
of 264 base pairs was obtained and sequenced, demonstrating that it 
corresponded to a human CKI gene due to its homology to the bovine 
sequence. This PCR fragment was labeled by random oligonucleotide 
primers [‘*P]dATP yielding a specific activity of IO9 cpm/pg and used 
as a probe to screen 5 x 10’ clones of the same human cDNA library. 
Seventeen clones were obtained after tertiary screening. Analysis of 
these clones demonstrated that only 8 had the complete coding region, 
the other ones being truncated. 
The size of the insert in one of the complete clones was approximately 
of 1,600 bp. This clone was rescued from the ;1ZAP phage to yield a 
Bluescript plasmid. This plasmid was purified and sequenced by the 
dideoxy method [9]. 
2.2. Screening of the YAC library 
Primers were designed using an oligonucleotide selection program 
[lo] on the published bovine CKla cDNA sequence [7]. The chosen 
primers were S-CTT AAA CTA TTG TCG TGG G-3’ and 3’-TCA 
TAT TGG TGA TTC AGG G-5’ corresponding to 1,170-1,188 and 
1,271-1,253 of the published sequence of bovine CKI and giving a 
product length of 102 bp. 
Screening of the YAC libraries was done entirely by PCR using 
standard methods [11,12]. Screening was done in the Center for Genet- 
ics in Medicine at Washington University by a robot-assisted hierarchi- 
cal identification scheme [13]. Two YAC libraries containing approxi- 
mately 5 genome equivalents were screened with the chosen primer pair. 
These libraries were both made from human lymphoblastoid cell lines 
(48, XXXX) [14] and (49, XXXXX) (Schlessinger, D., personal commu- 
nication). 
2.3. Alu-PCR and DNA labeling 
Alu-PCR was done on yeast clones as described by Lengauer, et al. 
[I 51. Briefly, agarose plugs containing yeast clones with human insert 
YACs were eauilibrated extensivelv in PCR-buffer (IO mM Tris-HCI, 
pH 8.4, 50 m’M KCl, 1.5 mM M&I,). Using 0.25 PM each of the 
primers CL1 (5’-TCC CAA AGT GCT GGG ATT ACA G-3’) and 
CL2 (5’~CTG CAC TCC AGC CTG GG-3’) PCR was carried out in 
PCR-buffer containing 100 ng DNA from a melted plug, 250 PM 
dNTPs and 5 units Taq polymerase (Perkin ElmerlCetus). After initial 
denaturation at 94°C for 3 min, 30 cycles of PCR were carried out with 
denaturation at 94’C for 1 min, a 2 min 30 s ramp to a 30 s annealing 
at 37”C, a 45 s ramp to a 6 min extension at 72°C with a 45 s ramp 
back to 94°C. Alu-PCR amplification products were labeled by incor- 
poration of biotin-1 I-dUTP (Sigma) by nick translation. DNAs in the 
range of 56800 bp with a median size of about 200 bp were used for 
the in situ hybridization experiments. 
2.4. In situ hybridization and probe detection 
Prometaphase chromosome spreads were obtained from PHA-stimu- 
lated normal male human lymphocytes using standard procedures [16], 
a BudR cocktail being used instead of thymidine as a release, to enable 
replication banding to be done. In situ hybridization and washing 
procedures were performed essentially as described by Lichter and 
Cremer [17] with modification. Briefly, pretreatment of the chromo- 
some slides was for 30-60 min at 65°C followed by RNase treatment 
(100 pg RNase A/ml 2 x SSC, 1 h. at 37”C), 3 rinses in 2 x SSC, pepsin 
treatment (50 &ml Pepsin in 0.01 M HCI, pH 2.3, incubated at 37°C 
for 10 min) washing in PBS, then fixation in 1% formaldehyde and 
finally ethanol dehydration. Hybridizations were done with 100 ng of 
biotin-labeled DNA from the different YACs, plus 80 pg human Cot1 
DNA (Gibco-BRL), 5 pg of sheared salmon sperm DNA and 5 /lg of 
E. coli tRNA in 10 ~1 of 10% dextran sulfate, 50% formamide, 2 x SSC, 
and were denatured at 73°C for 5 min, preannealed for 20 min at 37°C 
then applied to denatured slides (2 min in 70% formamide/ x SSC at 
7O’C followed by ethanol dehydration) under a 20 mm’ cover glass. 
Hybridization was overnight at 37°C followed by 3 washes of 5 min in 
50% formamide/ x SSC at 45°C and 0.1 x SSC at 60°C. Slides were 
blocked with 5% BSA/4 x SSC for 30 min and probe detection was with 
10 pg/rnl of fluorescein isothiocyanate (FITC) conjugated avidin (Vec- 
tor Laboratories) in 4 x SSC/O.2% Tween-20 for 30 min. Slides were 
washed 3 times at room temperature for 5 min in 4 x SSC containing 
0.2% Tween-20. Slides were then stained with Hoechst 33258 (0.5 pg/ 
ml) and irradiated for 30 min at a 20 cm distance from two 15 W 
ultaviolet bulbs. Signal was then amplified using the sandwich tech- 
nique of Pinkel et al. [18]. Finally slides were stained in DAPI and 
mounted. 
2.5. Image acquisition and enhancement 
Slides were examined under a Zeiss Axiovert fluorescent microscope. 
The DAPI replication banding was viewed with a ‘02’ filter set, the 
FITC signal with a ‘09’ filter set. Images were captured using a cooled 
CCD (Photometrics, Tucson, AZ) and displayed on a Macintosh com- 
puter. Images were processed as described in Featherstone and Huxley 
[19]. Chromosomes were identified by the DAPI replicational banding 
pattern. 
3. Results 
Using primers derived from the X. Levis CKla cDNA 
sequence and DNA from a human cDNA library, ampli- 
fication by PCR yielded the expected fragment of 264 bp. 
Sequencing of this fragment suggested that the amplifica- 
tion product corresponded to a fragment of the human 
sequence coding for CKla since it was highly homolo- 
gous to the bovine and X Zuevis equences. This frag- 
ment was labeled and used as a probe to screen the same 
human cDNA library. Four clones were purified 
through secondary and tertiary screening. Subcloning of 
one of these gave a bluescript plasmid containing a 
1,600 bp insert. The nucleotide sequence of this insert 
and the derived amino acid sequence are given in Fig. 1. 
The coding region defines a protein of 337 amino acids 
with a M, of 38,874 Da. This nucleotide sequence is 
highly homologous to the CKl CI species found in bovine 
and in X. laevis. Fig. 2 compares the derived amino acid 
sequence obtained from the human clone to that of the 
bovine CKla, rat CK16, and HRH25 of S. cerevisiue. A 
remarkable conservation is noted, since it is identical 
when compared to bovine CKla, except that the human 
protein has 12 additional amino acids at the carboxyl 
end. At the nucleotide level the human and bovine se- 
quences of the CI subspecies are 85% identical. 
Using the primers derived from the CKlol bovine se- 
quence as described in section 2, a human YAC library 
was screened and 3 YACs were found to be positive. 
With these YACs, and using PCR primers and condi- 
tions for amplification detailed in section 2, the expected 
102 bp PCR fragment was obtained. Upon sequencing, 
the fragment from all three YACs and human genomic 
DNA were found to be consistent with the known amino 
acid sequence of the human CKl. The fact that these 
YAC clones contained the CKl was verified by the fact 
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CCGCCTCCGTGTTCCGTTTCCTGCCGCCCTCCTCTCGTAG 
GGCCTCCGTCCTCTTCCCAGAGGTGTCGAGGCTTGGCCCCAGCCTCCATCTTCGTCTCTCAGG 
63 
ATGGCGAGTAGCAGCGGCTCCAAGGCTGAATTCATTGTCGT G GAAATATAAXTGGTACGG 
MASSSGSKAEF IVGGKYKLVR 
126 
A?iGilTCGGGTCTGGCTCCTTCGGGGACATCTATTTGGCGliTCAACATCACCAACGGCGA~ 
KIGSGSFGDIYLAI NITNGEE 
189 
GTGGCACTGAAGCTAGAATCTCAGIUUXC CAGGCATCCCCAGTTGCTGTACGAGAGCAAGCTC 
VAVKLESQKARHPQLLYESKL 
252 
TATAAGATTCTTCAAGGTGGGGTTGGCATCCCCCACATACGGTGGTATGGTCA-GAC 
YKILQGGVG IPHIRWYGQEKD 
315 
TACAATGTACTAGTCATGGATCTTCTGGGAC CTAGCCTCGAAGACCTCTTCAATTTCTGTTCA 
YNVLVMDLLGPSLEDLFNFCS 
378 
AGAAGGTTCACAATGAAAACTGTACTTATGTTAGCTGACCAGATGATCAGTAGAATTGAATAT 
RRFTMKTVLMLADQMI S RI E Y 
441 
CATGTGACAAAGAATTTTATACACAGAGACATTAAACCAGATAACTTCCTAATGGGTATTGGG 
HVTKNFIHRDIKPDNFLMGIG 
504 
CGTCACTGTAATAAGTTATTCCTTATTGATTTTGGTTTGGC CAAAAAGTACAGAGACAACAGG 
RHCNKLFLIDFGLAKKYRDNR 
567 
ACAAGGCAACACATACCATACAGAGAAGATAAAAACCTCACTGGCACTGCCGATTATGCTAGC 
T R Q HIPYREDKNLTGTADYAS 
630 
ATCAATGCACATCTTGGTATTGAGCAGAGTCGCCGAGATGACATGGAATCATTAGGATATGTT 
INAHLGIEQS RRDDMESLGYV 
693 
TTGATGTATTTTAATAGAACCAGCCTGCCATGGCAAGGGCTAAAGGCTGCAACAAAGAAACAA 
LMYFNRTSLPWQGLKAATKKQ 
756 
AAATAT-GATTAGTGAAAAGAAGATGTCCACGCCTGTTGAAGTTTTATGTAAGGGGTTT 
KYEKISEKKMSTPVEVLCKGF 
819 
CCTGCAGAATTTGCGATGTACTTAAACTATTGTCGTGGGCTACGCTTTGAGGAAGCCCCAGAT 
PAEFAMYLNYCRGLRFEEAPD 
882 
TACATGTATCTGAGGCAGCTATTCCGCATTCTTTTCAGGACCCTGZUUXATCAATATG7UZTAC 
IMYLRQLFRILFRTLNHQYDY 
945 
ACATTTGATTGGACAATGTTAAAGCA~GCAGCACAGCAGGCAGCCTCTTCAAGTGGGCAG 
TFDWTMLKQKAAQQAASSSGQ 
1008 
GGTCAGCAGGCCCAAACCCCCACAGGCAAGCAAACTGACAT 
GQQAQTPTGKQTDKTKSNMKG 
GTTTCTCCCCAAATCTAGAAATTTTTAGTTCATATGTACACTAGCCAGTGGTTGTGGACAACCA 
Fig. 1. Deoxynucleotide and derived amino acid sequences of a cDNA coding for human protein kinase CKla. 
that they hybridized with /ZZAP FA 603, one of the 
cDNA clones for CKla (data not shown). The YACs 
containing the human CKlcx gene were used to localize 
this gene by the use of fluorescent in situ hybridization 
(FISH). Fig. 3 shows a clear signal in 13q13 where the 
same location was observed with all the three YACs. 
Two gave a single signal and did not hybridize with any 
other region, but the third YAC also gave hybridization 
on 5q26 and 7~15.2. This YAC clone contained two 
different size YACs both of which were positive by 
Southern analysis and hybridization with the cDNA RA 
603. This clone would be expected therefore to be chim- 
eric, with the smaller YAC probably being a rearrange- 
ment of the larger. 
4. Discussion 
This communication reports the first cloning of a human 
gene coding for CKl. The amino acid sequence derived 
from the cDNA nucleotide sequence demonstrates that 
this clone corresponds to the 01 subspecies of CKl descri- 
bed in bovine brain [6]. Comparison of these sequences 
demonstrates a remarkable degree of conservation since 
there are no differences observed throughout the amino 
acid sequences, except that the human protein has 
12 additional amino acids at the carboxyl end. The 
human CKla has all the signature sequences conserved 
among all the CKls so far described such as LLGPS- 
LEDLF (residues 92-l 00), HIPXR (residues 172-l 76), 
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i II 
MASSSGSKAEF IVGGKYKLVRKIGSGSFGDIYLA IN ITNGEEVAVKLESQ 
MASSSGSKAEF IVGGKYKLVRKIGSGSFGDIYLA IN ITNGEEVAVKLESQ 
M . . . . . . . .  ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV 
M . . . . . . . .  DLRVGRKFRIGRKIGSGSFGDIYHGTNLISGEEVAIKLES I  
III IV V 
KARHPQLLYESKLYK ILQGGVGIPHIRWYGQEKDYNVLVMD~ 
KA_RHPQT.T.YESKLYKILQGGVGI PHI RWYGQEKDYNVLVMD~ 
KTKHPQLHIESK IYKMMQGGVGIPT IRWCGAEGDYNVMVME~ 
RSRHPQLDYESRVYRYLSGGVGIPF IRWFGREGEYNAMVI~ 
Via V Ib  ~ CSRRFTMKTVL~MISRIEYV~TKNFIHRDIKPDNFLMGIGRHC CSRRFTMXTVI~MISRIEYVHTKNFIHRDIKPDNFLMGIGRHC CSRKFSLKTVT,LTJkDQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG 
CHRRFSFKTVIMLALQMFCRIQY IHGRSF IHRDIKPDNFLMGVGRRG 
VI I  V I I I  
NKLFL  IDFGLAKKYRDNRTRQ~ DKNLTGTADYAS I NAHLGI I  
NKLFL I DFGLAKKYRDNRTRQ~E DKNLTGTARYAS INAHLGI~ 
NLVYI  I DFGLAKKYRDARTHQ~ENKNLTGTARYAS I NTHLGI~ 
STVHVI DFGLSKKYRDFNT~NKSLTGTARYASVNTHLGI~ 
IX X ~ SLGYVLMYFNRTS~TKKQKYEKISEKKMSTPVE%~CK SLGYVLMYFNRTS~TKKQKYEKISEKKMSTPVEVLCK SLGYVLMYFNLG~TKRQKYERISEKKMSTP IEVLCK 
SLGYVL IYFCKGS~~"~QKYDRIMEKKLNVSVETLCS 
XI 
GFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTM 
GFPAEFAMYLNYCRGLRFEEAPDYMYLRQLFRILFRTLNHQYDYTFDWTM 
GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 
GLPLEFQEYMAYCKNLKFDEKPDYLFLARLFKDLS IKLEYHNDHLFDWTM 
~Human 
aBovine 
8Rat 
HRR25 
LK  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
LK - - - -  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
LKFG .ASRAADDAERERRDREERL . . . . . . . . .  
LRYTKAMVEKQRDLLIEKGDLNANSNAASASNSTDNKSETFNKIE/ZLAMK 
aHuman 
aBovine 
8Rat 
HRR25 
. . . . . . . . . . . .  QKAAQQAASSSGQG . . . . .  QQAQTPT . . . . . . . . . . . .  
. . . . . . . . . . . .  QKAAQQAASSSGQG . . . . .  QQAQTPT . . . . . . . . . . . .  
. . . . . . . . .  RHSRNPATRGLPSTASGRLRGTQEVAPPTPL  . . . . . . . . . .  
KFPTHFHYYKNEDKHNPSPEE IKQQTILNNNAASSLPEE~DKGMEN 
aHuman 
=Bovine 
~Rat 
HRR25 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  GKQTDKTKSNMKGF* 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  GF* 
. . . .  TPTSHTANTSPRPVSGMERERKVSMRLH-   RGAPVNVSSSDLTGRQ 
LRQQQPQQQVQS QPQPQPQQLQQQPNGQRPNYYPEPLLQQQQRDSQEQQ 
8Rat DTSRMSTSQRSR-  - - DMASL~QGA . . . .  RCRPQRPRRTTY* 
HRR25 QQVPMATTRATQYPPQ I NSNNFNTNQASVPPQMRSNPQQPPQDKPAGQS I 
HRR25 WL* 
Fig. 2. Comparison of human CK 1 ~ amino acid sequences with CK 1 from different species, The Roman numerals correspond to the conserved regions 
present in the catalytic domain of protein kinases [27]. The shaded areas define regions that are conserved in all CK1 sequences [8]. Hyphens indicate 
spaces to optimize alignment. 
EXSRRDD (residues 197-203) and LPWQGLKA (resi- 
dues 219-226) as pointed out by Graves et al. [7]. 
The high level of conservation points to a protein with 
important, probably essential, cellular functions that tol- 
erate little structural variations. It is interesting that the 
human protein has an extended carboxyl tail in view of 
the fact that it has been recently demonstrated that exten- 
sion in this terminal segment S. pornbe in CK1 serves to 
down-regulate he activity of the enzyme [20]. 
This work did not attempt o look exhaustively for 
other members of the CK1 family in the human genome. 
However, two separately isolated cDNA clones, detected 
with a probe to a region that is common to all the bovine 
isoforms, gave identical nucleotide sequences. The par- 
tial nucleotide sequence obtained from PCR fragment 
from the YACs also corresponded to the same ~species. 
This may suggest that other members of the CK 1 family 
in the human may be sufficiently divergent not to be 
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Fig. 3. A replication banded human metaphase showing hybridization of a CKl YAC to chromosome 13q13. 
detected with the probes used or that these members are 
poorly expressed or not present in the libraries that were 
screened. 
The gene coding for the a species of human CKl is 
located in band q13 of chromosome 13. It is of consider- 
able interest that in the vicinity of the CKlol locus is the 
retinoblastoma locus which maps to 13q14.1-13q14.2 
[21]. In this same area is the gene for esterase D which 
maps to 13414.11 1221. FMS-like tyrosine kinases-1 and 
-3 both map to 13ql2 [23] and Moebius syndrome (con- 
genital facial diplegia) map to 13q12.2-q13 [24]. Some 
observations uggest a non-random involvement of band 
13q13 in chronic lymphoproliferative disease [25]. Of 
special interest is a previous report of an X-ray sensitivity 
locus in 13q14 [26] as there may be a relation to experi- 
ments in yeast that involve CKl in DNA repair [5]. 
The cloning and localization of the human CKla gene 
should be helpful in defining the in vivo function(s) of 
this enzyme. 
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